Potential of longitudinal data from single site and multi-center clinical trials for AI-research

Prof. Dr. Hans-Christoph Becker from Stanford University, a long-standing user of mint Lesion™, shares his experience of using the software in this brief interview. He talks about the reaction he received when sharing the mint report for the first time, how patients benefit from the longitudinal overview of disease, and his plans to use the structured data for AI research.

Click here or on the image above to watch the full video on YouTube.

Related Resources

Related Resources

MRT of the lung in mint Lesion

Standardized Reporting for COVID-19: mint Lesion introduces a new template

The COVID-19 pandemic has shown how vital rapid and standardized diagnostics are. Radiologists play a key role: CT imaging not only helps with early…

Clear, consistent, and complete documentation of imaging-derived information

The radiology report is expected to provide information that impacts life changing treatment decisions at every cancer care step in which imaging is…

Real-world data to enhance clinical trial evidence

In randomized controlled trials (RCTs), a vast proportion of patients does not meet the precise inclusion criteria. In oncology, for example,…